Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, ...

The resolution comes two months after the health regulator said there was no longer a shortage of Eli Lilly's weight-loss and ...

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity ...

The FDA declared the end of the shortage of Novo Nordisk’s Wegovy and Ozempic, impacting compounding pharmacies selling ...

Attorney General Kwame Raoul is leading a bipartisan coalition of 37 states and territories urging the Food and Drug ...

Hims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss ...

Dr. Darien Sutton and Dr. Stephanie Widmer discuss new studies, which found GLP-1 weight loss drugs beneficial in fighting Type 2 diabetes and certain addiction disorders. Semaglutide, the active ...

South Carolina Attorney General Alan Wilson announced he is leading 37 states on a territory bipartisan coalition requesting ...

“Researchers continue studying GLP-1 medications beyond diabetes and weight loss because they may have additional health benefits, such as reducing inflammation, improving lung ...

Eliminates or Reduces Medication Use Maintaining your ... Achieving type 2 diabetes remission through weight loss. Kline CE, Chasens ER, Bizhanova Z, et al. The association between sleep health ...

During my pregnancy last year, I explored the accessibility of GLP-1 receptor agonists (GLP-1RAs) - medications primarily designed to manage type 2 diabetes, but also prescribed for weight loss.